Product Name | C16 |
Description |
PKR kinase inhibitor |
Purity | >98% (HPLC) |
CAS No. | 608512-97-6 |
Molecular Formula | C13H8N4OS |
Molecular Weight | 268.3 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | Soluble in DMSO 12 mg/ml |
Source | Synthetic |
Appearance | Solid |
SMILES | C1=CC2=C(C3=C1NC(=O)/C3=CC4=CNC=N4)SC=N2 |
InChI | InChI=1S/C13H8N4OS/c18-13-8(3-7-4-14-5-15-7)11-9(17-13)1-2-10-12(11)19-6-16-10/h1-6H,(H,14,15)(H,17,18)/b8-3+ |
InChIKey | VFBGXTUGODTSPK-FPYGCLRLSA-N |
Safety Phrases |
Classification: Chronic aquatic toxicity (Category 4), H413 Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. Hazard statements: H413 May cause long lasting harmful effects to aquatic life. Precautionary statements: P273 Avoid release to the environment. P501 Dispose of contents/ container to an approved waste disposal plant. |
Cite This Product | C16 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-498) |
Alternative Names | Imidazolo-oxindole PKR inhibitor C16, 6,8-Dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo[2,3-g]benzothiazol-7-one |
Research Areas | Apoptosis, Cancer, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors |
PubChem ID | 67016828 |
Scientific Background | C16 is a derivative of imidazolo-oxindole and inhibits RNA-dependent protein kinases (PKR). Its inhibition effect on PKR is ATP-binding site directed. C16 has been shown to specifically inhibit the apoptotic PKR/eIF2a signaling pathway. |
References |
1. Couturier J., et al. (2010) J. Biol. Chem. 285(2): 1272–1282. 2. Jammi N.V., Whitby L.R., & Beal P.A. (2003) Biochem. Biophys.Res. Comm. 308(1):50–57. |
Reviews
There are no reviews yet.